Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 4,717 | 6,784 | 4,924 | 6,313 | 5,004 |
| Operating Income | -4,717 | -6,784 | -4,924 | -6,313 | -5,004 |
| Interest Expense | N/A | 0 | 515 | N/A | N/A |
| Other Income | 8 | 844 | 1,942 | -5 | 37 |
| Pre-tax Income | -4,709 | -5,940 | -3,496 | -6,319 | -4,968 |
| Net Income Continuous | -4,709 | -5,940 | -3,496 | -6,319 | -4,968 |
| Net Income | $-4,709 | $-5,940 | $-3,496 | $-6,319 | $-4,968 |
| EPS Basic Total Ops | -0.08 | -0.10 | -0.06 | -0.13 | -0.11 |
| EPS Basic Continuous Ops | -0.08 | -0.10 | -0.06 | -0.13 | -0.11 |
| EPS Diluted Total Ops | -0.08 | -0.10 | -0.06 | -0.13 | -0.11 |
| EPS Diluted Continuous Ops | -0.08 | -0.10 | -0.06 | -0.13 | -0.11 |
| EBITDA(a) | $-4,682 | $-5,905 | $-2,947 | $-6,279 | $-4,993 |